Filing Details

Accession Number:
0001570562-24-000095
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-06 19:01:24
Reporting Period:
2024-06-04
Accepted Time:
2024-06-06 19:01:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1570562 Evolus Inc. EOLS Pharmaceutical Preparations (2834) 461385614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1700836 David Moatazedi 520 Newport Center Dr.
Suite 1200
Newport Beach CA 92660
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-04 140,214 $12.73 533,349 No 4 S Direct
Common Stock Acquisiton 2024-06-05 155,278 $5.46 688,627 No 4 M Direct
Common Stock Disposition 2024-06-05 155,278 $12.92 533,349 No 4 S Direct
Common Stock Acquisiton 2024-06-06 175,940 $7.28 709,289 No 4 M Direct
Common Stock Disposition 2024-06-06 175,940 $12.59 533,349 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-06-05 155,278 $0.00 155,278 $5.46
Common Stock Stock Option (Right to Buy) Disposition 2024-06-06 175,940 $0.00 175,940 $7.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
155,281 2032-01-25 No 4 M Direct
1,006,079 2028-05-06 No 4 M Direct
Footnotes
  1. The shares were sold in multiple trades at prices ranging from $12.70 to $12.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. The shares were sold in multiple trades at prices ranging from $12.77 to $13.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The shares were sold in multiple trades at prices ranging from $12.40 to $12.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
  5. The shares subject to the option vested in full over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of May 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.